AI in Biotechnology Market by Function and End User

Description

List of Tables

The global AI in biotechnology market is projected to reach USD 22,716.5 million by 2035 from USD 4,156.9 million in 2025, at a high CAGR of 18.5% during the forecast period. The market is progressing steadily, driven by the growing adoption of AI for predictive analytics in drug safety and efficacy, the increasing use of AI-powered automation in laboratory processes, and the rising demand for cost-efficient and accelerated research pipelines.

Scope of the Report
Years Considered for the Study	2024-2035
Base Year	2024
Forecast Period	2025-2035
Units Considered	Value (USD million)
Segments	Offering, Function, Deployment Mode, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Middle East & Africa, Latin America

Moreover, the expanding availability of large-scale biological datasets, advancements in cloud computing infrastructure, and supportive government initiatives promoting AI in life sciences further propel market growth. The convergence of AI with emerging biotechnologies is enabling faster innovation, improved decision-making, and more personalized healthcare solutions.

"The research & development segment of the AI in biotechnology market is the largest segment during the forecast period."

Based on function, the research & development (R&D) segment accounted for the largest share of the AI in biotechnology market and is projected to maintain its lead in the coming years. This dominance is driven by the increasing use of AI to accelerate drug discovery, optimize molecular design, and predict compound efficacy and safety. AI-powered tools enable researchers to analyze large-scale genomic, proteomic, and clinical datasets more efficiently, reducing experimental timelines and costs. Additionally, the integration of machine learning algorithms with high-throughput screening and automated laboratory platforms is enhancing the precision and scalability of R&D processes. As biotech companies strive to bring novel therapeutics to market faster, the adoption of AI in R&D continues to be a key growth driver.

"Based on the end user, the pharmaceutical companies segment accounted for the largest share of AI in biotechnology market during the forecast period."

The pharmaceutical companies segment accounted for the largest share of the AI in biotechnology market during the forecast period. This growth is driven by the increasing adoption of AI for accelerating drug discovery, optimizing clinical trial design, and predicting drug efficacy and safety profiles. Pharmaceutical firms are leveraging AI to analyze large-scale biological and clinical datasets, identify novel drug targets, and streamline R&D workflows, reducing time and cost. Additionally, AI-enabled predictive modeling and virtual screening tools help companies make data-driven decisions, enhance success rates, and bring new therapies to market more efficiently. The rising demand for personalized medicine and the pressure to innovate rapidly further reinforce the adoption of AI within the pharmaceutical sector.

"Asia Pacific is projected to witness the highest growth rate during the forecast period."

The Asia Pacific region is projected to witness the highest growth rate in the AI in biotechnology market during the forecast period. This rapid expansion is driven by a strong focus on technological advancement and research excellence. Countries across the region are strengthening their innovation ecosystems through enhanced infrastructure, academic-industry partnerships, and cross-border collaborations. The growing emphasis on precision medicine, data-driven healthcare, and sustainable biomanufacturing is also creating new opportunities for market development. Moreover, supportive regulatory frameworks and increasing public-private initiatives position Asia Pacific as a global hub for next-generation biotechnological progress.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the AI in biotechnology marketplace. The breakdown of primary participants is as mentioned below:

By Company Type - Tier 1: 34%, Tier 2: 46%, and Tier 3: 20%
By Designation - C-Level: 35%, Director Level: 25%, and Others: 40%
By Region - North America: 30%, Europe: 45%, Asia Pacific: 20%, Latin America: 3%, Middle East & Africa: 2%

Key Players in the AI in Biotechnology Market

The key players operating in the AI in biotechnology market include NVIDIA (US), Illumina, Inc. (US), Recursion (US), Schrodinger, Inc. (US), BenevolentAI (UK), Data4Cure, Inc. (US), Qiagen (Germany), Insilico Medicine (US), DNAnexus, Inc. (US), Tempus (US), SOPHiA GENETIC (Switzerland), Predictive Oncology (US), Deep Genomics (Canada), NuMedii, Inc. (US), XtalPi Inc. (China), Iktos (France), BPGbio, Inc. (US), Eurofins Discovery (US), VeriSIM Life (US), Lifebit (UK), Verge Genomics (US), Logica (US), American Chemical Society (US), and Aganitha AI Inc. (India).

Research Coverage

The report analyzes the AI in biotechnology market and aims to estimate the market size and future growth potential of various market segments, based on offering, function, deployment mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will benefit established firms as well as new entrants and smaller firms in gauging the market pulse, which in turn will help them capture a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights into the following:

Analysis of key drivers (growing cross-industry collaborations and partnerships, growing need to reduce time and cost of drug discovery and development, rising adoption of AI in precision medicine, improving computing power and declining hardware cost), restraints (high implementation costs of AI limit adoption in biotechnology, especially for SMEs and emerging economies, data privacy risks and compliance challenges for AI in biotechnology), opportunities (integrating AI and big data in precision medicine for biotechnology advancement, surge in biotechnology investments enhances opportunities for AI to accelerate drug discovery innovations, innovation across healthcare, agriculture, and environmental science for global growth) challenges (data quality and interpretability issues that hinder AI integration and trustworthiness, AI deployment in biotechnology hindered by talent shortages and evolving regulatory challenges) influencing the growth of the AI in biotechnology market
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the AI in biotechnology market
Market Development: Comprehensive information on the lucrative emerging markets, offering, function, deployment mode, end user, and region
Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the AI in biotechnology market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the AI in biotechnology market, like NVIDIA (US), Illumina, Inc. (US), Recursion (US), Schrodinger Inc. (US), and BenevolentAI (UK)

Product Code: HIT 9205

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Key data from primary sources
  - 2.1.2.2 Insights from primary experts
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
- 2.6.1 METHODOLOGY-RELATED LIMITATIONS
- 2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 AI IN BIOTECHNOLOGY MARKET OVERVIEW
4.2 AI IN BIOTECHNOLOGY MARKET, BY REGION
4.3 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING AND COUNTRY
4.4 AI IN BIOTECHNOLOGY MARKET: GEOGRAPHIC SNAPSHOT
4.5 AI IN BIOTECHNOLOGY MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Growing cross-industry collaborations and partnerships
  - 5.2.1.2 Increasing need to reduce time and cost of drug discovery & development
  - 5.2.1.3 Rising adoption of AI in precision medicine
  - 5.2.1.4 Increasing investments in semiconductor chipsets
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High implementation costs
  - 5.2.2.2 Data privacy risks and compliance challenges
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Rise of advanced analytics and predictive modeling
  - 5.2.3.2 Surge in biotechnology investments
  - 5.2.3.3 Innovations across healthcare, agriculture, and environmental science
- 5.2.4 CHALLENGES
  - 5.2.4.1 Data quality and interpretability issues
  - 5.2.4.2 Shortage of qualified experts and evolving regulatory challenges
5.3 UNMET NEEDS AND WHITE SPACES
5.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
5.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS

6 INDUSTRY TRENDS

6.1 EVOLUTION OF AI IN BIOTECHNOLOGY
6.2 PORTER'S FIVE FORCES ANALYSIS
- 6.2.1 BARGAINING POWER OF SUPPLIERS
- 6.2.2 BARGAINING POWER OF BUYERS
- 6.2.3 THREAT OF SUBSTITUTES
- 6.2.4 THREAT OF NEW ENTRANTS
- 6.2.5 INTENSITY OF COMPETITIVE RIVALRY
6.3 MACROECONOMICS INDICATORS
- 6.3.1 INTRODUCTION
- 6.3.2 GDP TRENDS AND FORECAST
- 6.3.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
6.4 VALUE CHAIN ANALYSIS
6.5 ECOSYSTEM ANALYSIS
6.6 PRICING ANALYSIS
- 6.6.1 INDICATIVE PRICING ANALYSIS FOR AI IN BIOTECHNOLOGY, BY OFFERING, BY KEY PLAYERS (2024)
- 6.6.2 INDICATIVE PRICING OF AI IN BIOTECHNOLOGY, BY REGION
6.7 KEY CONFERENCES AND EVENTS, 2025-2026
6.8 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
6.9 INVESTMENT AND FUNDING SCENARIO
6.10 CASE STUDY ANALYSIS
- 6.10.1 CASE STUDY 1: RAPID TRAINING OF PROTEIN MODELS USING NVIDIA DGX CLOUD
- 6.10.2 CASE STUDY 2: IMPROVED END-TO-END NGS WORKFLOW FOR EFFICIENT GENETIC VARIANT DETECTION
- 6.10.3 CASE STUDY 3: ACCELERATED DRUG DISCOVERY WITH GENERATIVE AI AND STREAMLINED WORKFLOWS
6.11 IMPACT OF 2025 US TARIFF ON AI IN BIOTECHNOLOGY MARKET
- 6.11.1 INTRODUCTION
- 6.11.2 KEY TARIFF RATES
- 6.11.3 PRICE IMPACT ANALYSIS
- 6.11.4 IMPACT ON COUNTRIES/REGIONS
  - 6.11.4.1 North America
  - 6.11.4.2 Europe
  - 6.11.4.3 Asia Pacific
- 6.11.5 IMPACT ON END-USE INDUSTRIES
  - 6.11.5.1 Pharmaceutical companies
  - 6.11.5.2 Biotechnology companies
  - 6.11.5.3 Research institutes and labs
  - 6.11.5.4 Healthcare providers
  - 6.11.5.5 Contract Research Organizations (CROs)

7 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

7.1 KEY EMERGING TECHNOLOGIES
- 7.1.1 NATURAL LANGUAGE PROCESSING (NLP)
- 7.1.2 PREDICTIVE ANALYTICS
7.2 COMPLEMENTARY TECHNOLOGIES
- 7.2.1 CLOUD COMPUTING
- 7.2.2 BIG DATA ANALYTICS
7.3 TECHNOLOGY/PRODUCT ROADMAP
7.4 PATENT ANALYSIS
- 7.4.1 PATENT PUBLICATION TRENDS FOR AI IN BIOTECHNOLOGY
- 7.4.2 JURISDICTION AND TOP APPLICANT ANALYSIS
7.5 FUTURE APPLICATIONS
- 7.5.1 AI-ENABLED PRECISION DISCOVERY AND MULTI-OMICS INTEGRATION
- 7.5.2 GENERATIVE BIOLOGY AND AUTOMATED DESIGN OF MOLECULES, PROTEINS, AND GENETIC SYSTEMS
7.6 IMPACT OF AI/GEN AI ON AI IN BIOTECHNOLOGY MARKET
- 7.6.1 INTRODUCTION
- 7.6.2 TOP USE CASES AND MARKET POTENTIAL
- 7.6.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  - 7.6.3.1 Drug discovery and development market
  - 7.6.3.2 Genomics and bioinformatics market
  - 7.6.3.3 Medical imaging & diagnostics market
- 7.6.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN AI IN BIOTECHNOLOGY MARKET
  - 7.6.4.1 User readiness
    - 7.6.4.1.1 Pharmaceutical companies
    - 7.6.4.1.2 Biotechnology companies
  - 7.6.4.2 Impact assessment
    - 7.6.4.2.1 User A: Pharmaceutical companies
      - 7.6.4.2.1.1 Implementation
      - 7.6.4.2.1.2 Impact
    - 7.6.4.2.2 User B: Biotechnology companies
      - 7.6.4.2.2.1 Implementation
      - 7.6.4.2.2.2 Impact
- 7.6.5 CASE STUDY ON AI/GENERATIVE AI IMPLEMENTATION
  - 7.6.5.1 Case Study 1: Enhanced operations and revenue using AI-driven real-world data analytics
  - 7.6.5.2 Case study 2: Advance AI-powered target discovery with proprietary AI platform

8 REGULATORY LANDSCAPE

8.1 REGIONAL REGULATIONS AND COMPLIANCE
- 8.1.1 NORTH AMERICA
- 8.1.2 EUROPE
- 8.1.3 ASIA PACIFIC
- 8.1.4 LATIN AMERICA
- 8.1.5 MIDDLE EAST & AFRICA
8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8.3 INDUSTRY STANDARDS

9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

9.1 DECISION-MAKING PROCESS
9.2 INFLUENCE OF STAKEHOLDERS AND BUYING CRITERIA
- 9.2.1 BUYING CRITERIA
9.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
9.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9.5 END-USER EXPECTATIONS

10 AI IN BIOTECHNOLOGY MARKET, BY OFFERING

10.1 INTRODUCTION
10.2 END-TO-END SOLUTIONS
- 10.2.1 GROWING USE OF ADVANCED ALGORITHMS FOR BETTER PRECISION AND EFFICIENCY TO BOOST MARKET GROWTH
10.3 NICHE SOLUTIONS
- 10.3.1 ABILITY OF NICHE SOLUTIONS TO ADDRESS SPECIFIC CHALLENGES WITHIN DRUG DISCOVERY TO SUPPORT ADOPTION
10.4 TECHNOLOGIES
- 10.4.1 ADOPTION OF ADVANCED TECHNOLOGIES FOR DRUG DISCOVERY, PERSONALIZED MEDICINE, AND DATA ANALYTICS TO FUEL GROWTH
10.5 SERVICES
- 10.5.1 CONSULTING SERVICES
  - 10.5.1.1 Increasing efficiency of research processes and cost savings to boost adoption
- 10.5.2 IMPLEMENTATION SERVICES & ONGOING IT SUPPORT
  - 10.5.2.1 Increasing precision and efficiency in IT support services to boost demand
- 10.5.3 TRAINING & EDUCATION SERVICES
  - 10.5.3.1 Need for skilled talent for better training & education services to drive market
- 10.5.4 POST-SALES & MAINTENANCE SERVICES
  - 10.5.4.1 Complexity of AI systems and need for improvement in AI algorithms to boost market

11 AI IN BIOTECHNOLOGY MARKET, BY FUNCTION

11.1 INTRODUCTION
11.2 RESEARCH & DEVELOPMENT
- 11.2.1 DRUG DISCOVERY
  - 11.2.1.1 Molecular design & optimization
    - 11.2.1.1.1 Increased efficiency in drug discovery with molecular design & optimization to drive market
  - 11.2.1.2 Biomarker discovery
    - 11.2.1.2.1 Ability to analyze large data sets with AI-enabled biomarker discovery to boost demand
  - 11.2.1.3 Structure-activity relationship (SAR) modeling
    - 11.2.1.3.1 Improved data analysis, predictive modeling, and compound optimization for drug candidates with SAR to fuel growth
- 11.2.2 CLINICAL DEVELOPMENT
  - 11.2.2.1 Trial design
    - 11.2.2.1.1 Ability of AI to improve trial design through simulations and patient stratification to favor market
  - 11.2.2.2 Site selection
    - 11.2.2.2.1 Optimized process of selecting clinical trial sites to fuel growth
  - 11.2.2.3 Recruitment
    - 11.2.2.3.1 Enhanced process of selecting and enrolling participants for clinical trials to drive demand
  - 11.2.2.4 Clinical data assessment
    - 11.2.2.4.1 Ability of clinical data assessment for efficient and accurate of data interpretation to propel market
  - 11.2.2.5 Predictive toxicity & risk monitoring
    - 11.2.2.5.1 Ability of data integration and predictive modeling to create comprehensive risk profiles for drug candidates
  - 11.2.2.6 Monitoring & drug adherence
    - 11.2.2.6.1 Enhanced patient compliance with monitoring and drug adherence to drive market
  - 11.2.2.7 Real-world evidence (RWE) analysis
    - 11.2.2.7.1 Enhanced safety monitoring and economic evaluation with RWE analysis to propel growth
11.3 REGULATORY COMPLIANCE
- 11.3.1 ABILITY OF AI TO ENSURE REGULATORY COMPLIANCE IN CLINICAL TRIALS TO SUPPORT GROWTH
11.4 MANUFACTURING & SUPPLY CHAIN
- 11.4.1 SUPPLY CHAIN PLANNING
  - 11.4.1.1 Increasing demand for real-time data analytics to accelerate market growth
- 11.4.2 INVENTORY MANAGEMENT
  - 11.4.2.1 Automating stock tracking and replenishment with advanced analytics to fuel market growth
- 11.4.3 LOGISTICS OPTIMIZATION
  - 11.4.3.1 Ability of AI for increased collaboration and transparency in biotechnology logistics to aid growth
- 11.4.4 DEMAND FORECASTING
  - 11.4.4.1 Ability to integrate data for a reliable demand forecast to fuel market growth
- 11.4.5 PREDICTIVE MAINTENANCE
  - 11.4.5.1 Boosting equipment reliability with AI-powered predictive maintenance to drive demand
- 11.4.6 OTHER MANUFACTURING & SUPPLY CHAIN FUNCTIONS
11.5 LAUNCH & COMMERCIAL
- 11.5.1 LAUNCH COORDINATION
  - 11.5.1.1 Increasing product launch success rates through predictive analytics to boost adoption
- 11.5.2 PATIENT ENGAGEMENT
  - 11.5.2.1 Real-time patient feedback for better health outcomes to support growth
- 11.5.3 MARKETING OPERATIONS
  - 11.5.3.1 Enhanced marketing performance with AI to boost market growth
- 11.5.4 PREDICTIVE PRICING
  - 11.5.4.1 Ability of AI to enhance pricing accuracy to drive adoption
11.6 POST-MARKETING SURVEILLANCE & PATIENT SUPPORT
- 11.6.1 MEDICATION ADHERENCE
  - 11.6.1.1 Growing demand for personalized treatment plans to drive market
- 11.6.2 ADVERSE EVENT REPORTING
  - 11.6.2.1 Faster post-market surveillance and enhanced drug safety to drive demand
- 11.6.3 PATIENT MONITORING
  - 11.6.3.1 Rise of remote healthcare solutions to boost market demand
- 11.6.4 COMPLIANCE MONITORING
  - 11.6.4.1 Increasing complexity of regulatory requirements to drive adoption
- 11.6.5 PATIENT SUPPORT PROGRAMS
  - 11.6.5.1 Growing interest in patient-centered care to support market growth
11.7 CORPORATE
- 11.7.1 RISK MANAGEMENT
  - 11.7.1.1 Rising expenditure for drug development to support growth
- 11.7.2 COMPLIANCE MONITORING
  - 11.7.2.1 Strict guidelines for complex regulatory landscapes to aid market growth
- 11.7.3 SALES FORCE OPTIMIZATION
  - 11.7.3.1 Need for data-driven decision-making to boost adoption of sales force optimization
- 11.7.4 OTHER CORPORATE FUNCTIONS

12 AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE

12.1 INTRODUCTION
12.2 CLOUD-BASED SOLUTIONS
- 12.2.1 PUBLIC CLOUD
  - 12.2.1.1 Need to reduce dependency on expensive on-premises infrastructure to boost demand
- 12.2.2 PRIVATE CLOUD
  - 12.2.2.1 Need for enhanced security and data protection to propel market growth
- 12.2.3 MULTI-CLOUD
  - 12.2.3.1 Enhanced flexibility and cost optimization to support market growth
- 12.2.4 HYBRID CLOUD
  - 12.2.4.1 Cost efficiency and flexibility of hybrid cloud models to fuel market growth
12.3 ON-PREMISES SOLUTIONS
- 12.3.1 BETTER DATA SECURITY, PRIVACY, AND COMPLIANCE WITH REGULATIONS TO FAVOR GROWTH

13 AI IN BIOTECHNOLOGY MARKET, BY END USER

13.1 INTRODUCTION
13.2 PHARMACEUTICAL COMPANIES
- 13.2.1 INNOVATION AND EFFICIENCY WITH AI INTEGRATION IN DRUG DISCOVERY & DEVELOPMENT TO BOOST ADOPTION
13.3 BIOTECHNOLOGY COMPANIES
- 13.3.1 ABILITY OF AI-DRIVEN INNOVATIONS FOR BETTER PERSONALIZED MEDICINE AND DRUG DISCOVERY TO SUPPORT MARKET GROWTH
13.4 RESEARCH INSTITUTES & LABS
- 13.4.1 STRATEGIC INVESTMENTS AND COLLABORATIONS TO PROPEL AI ADVANCEMENTS IN RESEARCH INSTITUTES AND LABS
13.5 HEALTHCARE PROVIDERS
- 13.5.1 IMPROVED PATIENT OUTCOMES TO SUPPORT ADOPTION
13.6 CONTRACT RESEARCH ORGANIZATIONS
- 13.6.1 ABILITY OF AI TECHNOLOGIES TO ACCELERATE CLINICAL TRIALS AND IMPROVE PATIENT RECRUITMENT TO FUEL GROWTH

14 AI IN BIOTECHNOLOGY MARKET, BY REGION

14.1 INTRODUCTION
14.2 NORTH AMERICA
- 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 14.2.2 US
  - 14.2.2.1 US to dominate North American AI in biotechnology market during study period
- 14.2.3 CANADA
  - 14.2.3.1 Availability of advanced facilities and shorter approval times for drug candidates to drive market
14.3 EUROPE
- 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 14.3.2 GERMANY
  - 14.3.2.1 Increased funding in startups to drive uptake of AI in biotechnology
- 14.3.3 UK
  - 14.3.3.1 Increasing investments and government fund allocations to drive market
- 14.3.4 FRANCE
  - 14.3.4.1 Government initiatives in France to support market growth
- 14.3.5 ITALY
  - 14.3.5.1 Growing investments to create opportunities for market growth
- 14.3.6 SPAIN
  - 14.3.6.1 Increasing need for personalized medicine and data-driven healthcare to increase adoption rate in market
- 14.3.7 REST OF EUROPE
14.4 ASIA PACIFIC
- 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 14.4.2 JAPAN
  - 14.4.2.1 Accelerating AI-driven drug discovery and biotechnology innovation to drive Japanese market
- 14.4.3 CHINA
  - 14.4.3.1 Rising foreign investments in biotechnology and biopharmaceuticals to propel market growth
- 14.4.4 INDIA
  - 14.4.4.1 Increasing number of startups and growing support from government to propel market growth
- 14.4.5 SOUTH KOREA
  - 14.4.5.1 Significant advances in AI integration for R&D to fuel growth
- 14.4.6 AUSTRALIA
  - 14.4.6.1 Accelerating AI adoption in Australia's biotech sector to augment market growth
- 14.4.7 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
- 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 14.5.2 BRAZIL
  - 14.5.2.1 Funding of biotech companies to drive Brazilian market growth
- 14.5.3 MEXICO
  - 14.5.3.1 Investment inflows and strengthening AI-related education to spur market growth
- 14.5.4 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
- 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 14.6.2 GCC COUNTRIES
  - 14.6.2.1 Increase in healthcare investments to support market growth
- 14.6.3 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN AI IN BIOTECHNOLOGY MARKET
15.3 REVENUE ANALYSIS, 2020-2024
15.4 MARKET SHARE ANALYSIS, 2024
- 15.4.1 RANKING OF KEY MARKET PLAYERS
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 15.5.1 STARS
- 15.5.2 EMERGING LEADERS
- 15.5.3 PERVASIVE PLAYERS
- 15.5.4 PARTICIPANTS
- 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 15.5.5.1 Company footprint
  - 15.5.5.2 Region footprint
  - 15.5.5.3 Component footprint
  - 15.5.5.4 Function footprint
  - 15.5.5.5 End-user footprint
15.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
- 15.6.1 PROGRESSIVE COMPANIES
- 15.6.2 RESPONSIVE COMPANIES
- 15.6.3 DYNAMIC COMPANIES
- 15.6.4 STARTING BLOCKS
- 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 15.6.5.1 Detailed list of key startups/SMEs
  - 15.6.5.2 Competitive benchmarking of key startups/SME players
15.7 COMPANY VALUATION & FINANCIAL METRICS
- 15.7.1 FINANCIAL METRICS
- 15.7.2 COMPANY VALUATION
15.8 BRAND/PRODUCT COMPARISON
15.9 COMPETITIVE SCENARIO
- 15.9.1 PRODUCT LAUNCHES & UPGRADES
- 15.9.2 DEALS
- 15.9.3 EXPANSIONS

16 COMPANY PROFILES

16.1 KEY PLAYERS
- 16.1.1 NVIDIA CORPORATION
  - 16.1.1.1 Business overview
  - 16.1.1.2 Products offered
  - 16.1.1.3 Recent developments
    - 16.1.1.3.1 Product launches
    - 16.1.1.3.2 Deals
  - 16.1.1.4 MnM view
    - 16.1.1.4.1 Right to win
    - 16.1.1.4.2 Strategic choices
    - 16.1.1.4.3 Weaknesses & competitive threats
- 16.1.2 ILLUMINA, INC.
  - 16.1.2.1 Business overview
  - 16.1.2.2 Products offered
  - 16.1.2.3 Recent developments
    - 16.1.2.3.1 Product launches
    - 16.1.2.3.2 Deals
  - 16.1.2.4 MnM view
    - 16.1.2.4.1 Right to win
    - 16.1.2.4.2 Strategic choices
    - 16.1.2.4.3 Weaknesses & competitive threats
- 16.1.3 RECURSION
  - 16.1.3.1 Business overview
  - 16.1.3.2 Products offered
  - 16.1.3.3 Recent developments
    - 16.1.3.3.1 Product launches
    - 16.1.3.3.2 Deals
    - 16.1.3.3.3 Expansions
    - 16.1.3.3.4 Other developments
  - 16.1.3.4 MnM view
    - 16.1.3.4.1 Right to win
    - 16.1.3.4.2 Strategic choices
    - 16.1.3.4.3 Weaknesses & competitive threats
- 16.1.4 SCHRODINGER, INC.
  - 16.1.4.1 Business overview
  - 16.1.4.2 Products offered
  - 16.1.4.3 Recent developments
    - 16.1.4.3.1 Product upgrades
    - 16.1.4.3.2 Deals
    - 16.1.4.3.3 Other developments
  - 16.1.4.4 MnM view
    - 16.1.4.4.1 Right to win
    - 16.1.4.4.2 Strategic choices
    - 16.1.4.4.3 Weaknesses & competitive threats
- 16.1.5 BENEVOLENTAI
  - 16.1.5.1 Business overview
  - 16.1.5.2 Products offered
  - 16.1.5.3 Recent developments
    - 16.1.5.3.1 Deals
    - 16.1.5.3.2 Other developments
  - 16.1.5.4 MnM view
    - 16.1.5.4.1 Right to win
    - 16.1.5.4.2 Strategic choices
    - 16.1.5.4.3 Weaknesses & competitive threats
- 16.1.6 DATA4CURE, INC.
  - 16.1.6.1 Business overview
  - 16.1.6.2 Products offered
  - 16.1.6.3 Recent developments
    - 16.1.6.3.1 Deals
- 16.1.7 QIAGEN
  - 16.1.7.1 Business overview
  - 16.1.7.2 Products offered
  - 16.1.7.3 Recent developments
    - 16.1.7.3.1 Product launches and enhancements
    - 16.1.7.3.2 Deals
- 16.1.8 INSILICO MEDICINE
  - 16.1.8.1 Business overview
  - 16.1.8.2 Products offered
  - 16.1.8.3 Recent developments
    - 16.1.8.3.1 Product launches, approvals, and enhancements
    - 16.1.8.3.2 Deals
    - 16.1.8.3.3 Other developments
- 16.1.9 DNANEXUS, INC.
  - 16.1.9.1 Business overview
  - 16.1.9.2 Products offered
  - 16.1.9.3 Recent developments
    - 16.1.9.3.1 Deals
    - 16.1.9.3.2 Other developments
- 16.1.10 TEMPUS
  - 16.1.10.1 Business overview
  - 16.1.10.2 Products offered
  - 16.1.10.3 Recent developments
    - 16.1.10.3.1 Product approvals
    - 16.1.10.3.2 Deals
    - 16.1.10.3.3 Other developments
- 16.1.11 SOPHIA GENETICS
  - 16.1.11.1 Business overview
  - 16.1.11.2 Products offered
  - 16.1.11.3 Recent developments
    - 16.1.11.3.1 Product launches
    - 16.1.11.3.2 Deals
    - 16.1.11.3.3 Other developments
- 16.1.12 PREDICTIVE ONCOLOGY
  - 16.1.12.1 Business overview
  - 16.1.12.2 Products offered
  - 16.1.12.3 Recent developments
    - 16.1.12.3.1 Product launches
    - 16.1.12.3.2 Deals
    - 16.1.12.3.3 Expansions
- 16.1.13 DEEP GENOMICS
  - 16.1.13.1 Business overview
  - 16.1.13.2 Products offered
  - 16.1.13.3 Recent developments
    - 16.1.13.3.1 Product launches
- 16.1.14 NUMEDII, INC.
  - 16.1.14.1 Business overview
  - 16.1.14.2 Products offered
- 16.1.15 XTALPI INC.
  - 16.1.15.1 Business overview
  - 16.1.15.2 Products offered
  - 16.1.15.3 Recent developments
    - 16.1.15.3.1 Deals
- 16.1.16 IKTOS
  - 16.1.16.1 Business overview
  - 16.1.16.2 Products offered
  - 16.1.16.3 Recent developments
    - 16.1.16.3.1 Product launches
    - 16.1.16.3.2 Deals
    - 16.1.16.3.3 Other developments
- 16.1.17 BPGBIO, INC.
  - 16.1.17.1 Business overview
  - 16.1.17.2 Products offered
  - 16.1.17.3 Recent developments
    - 16.1.17.3.1 Product launches
    - 16.1.17.3.2 Deals
    - 16.1.17.3.3 Other developments
- 16.1.18 EUROFINS DISCOVERY
  - 16.1.18.1 Business overview
  - 16.1.18.2 Products offered
  - 16.1.18.3 Recent developments
    - 16.1.18.3.1 Product launches
    - 16.1.18.3.2 Deals
    - 16.1.18.3.3 Expansions
16.2 OTHER PLAYERS
- 16.2.1 VERISIM LIFE
- 16.2.2 LIFEBIT BIOTECH INC.
- 16.2.3 VALO HEALTH
- 16.2.4 VERGE GENOMICS
- 16.2.5 LOGICA
- 16.2.6 AMERICAN CHEMICAL SOCIETY
- 16.2.7 AGANITHA AI INC.

17 APPENDIX

17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS

Product Code: HIT 9205

List of Tables

TABLE 1 AI IN BIOTECHNOLOGY MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3 AI IN BIOTECHNOLOGY MARKET: RESEARCH ASSUMPTIONS
TABLE 4 AI IN BIOTECHNOLOGY MARKET: RISK ASSESSMENT
TABLE 5 AI IN BIOTECHNOLOGY MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 6 INDICATIVE LIST OF COLLABORATIONS AND PARTNERSHIPS IN AI IN BIOTECHNOLOGY MARKET, 2022-2025
TABLE 7 TABLE AI IN BIOTECHNOLOGY MARKET: UNMET NEEDS
TABLE 8 AI IN BIOTECHNOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 9 FIGURE 5 AI IN BIOTECHNOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 10 TABLE INDICATIVE PRICING ANALYSIS FOR AI IN BIOTECHNOLOGY OFFERINGS, BY KEY PLAYER, 2024 (USD)
TABLE 11 TABLE INDICATIVE PRICING ANALYSIS FOR AI IN BIOTECHNOLOGY, BY REGION (2024)
TABLE 12 AI IN BIOTECHNOLOGY MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
TABLE 13 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 14 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES, 2015-2025
TABLE 15 TABLE AI IN BIOTECHNOLOGY MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2022-2025
TABLE 16 REGULATORY SCENARIO OF NORTH AMERICA
TABLE 17 REGULATORY SCENARIO OF EUROPE
TABLE 18 REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 19 REGULATORY SCENARIO OF LATIN AMERICA
TABLE 20 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 21 TABLE NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 TABLE EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 TABLE ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 TABLE REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 27 UNMET NEEDS IN AI IN BIOTECHNOLOGY MARKET
TABLE 28 TABLE END-USER EXPECTATIONS IN AI IN BIOTECHNOLOGY MARKET
TABLE 29 AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 30 AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 31 AI IN BIOTECHNOLOGY MARKET FOR END-TO-END SOLUTIONS, BY REGION, 2023-2029 (USD MILLION)
TABLE 32 AI IN BIOTECHNOLOGY MARKET FOR END-TO-END SOLUTIONS, BY REGION, 2030-2035 (USD MILLION)
TABLE 33 AI IN BIOTECHNOLOGY MARKET FOR NICHE SOLUTIONS, BY REGION, 2023-2029 (USD MILLION)
TABLE 34 AI IN BIOTECHNOLOGY MARKET FOR NICHE SOLUTIONS, BY REGION, 2030-2035 (USD MILLION)
TABLE 35 AI IN BIOTECHNOLOGY MARKET FOR TECHNOLOGIES, BY REGION, 2023-2029 (USD MILLION)
TABLE 36 AI IN BIOTECHNOLOGY MARKET FOR TECHNOLOGIES, BY REGION, 2030-2035 (USD MILLION)
TABLE 37 AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY REGION, 2023-2029 (USD MILLION)
TABLE 38 AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY REGION, 2030-2035 (USD MILLION)
TABLE 39 CONSULTING SERVICES MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 40 CONSULTING SERVICES MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 41 IMPLEMENTATION SERVICES & ONGOING IT SUPPORT MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 42 IMPLEMENTATION SERVICES & ONGOING IT SUPPORT MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 43 TRAINING AND EDUCATION SERVICES MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 44 TRAINING AND EDUCATION SERVICES MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 45 POST-SALES AND MAINTENANCE SERVICES MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 46 AI IN BIOTECHNOLOGY MARKET FOR POST-SALES AND MAINTENANCE SERVICES, BY REGION, 2030-2035 (USD MILLION)
TABLE 47 AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 48 AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 49 AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 50 AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 51 AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2023-2029 (USD MILLION)
TABLE 52 AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2030-2035 (USD MILLION)
TABLE 53 EXAMPLES OF AI TOOLS USED IN DRUG DISCOVERY
TABLE 54 DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 55 DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 56 DRUG DISCOVERY MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 57 DRUG DISCOVERY MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 58 MOLECULAR DESIGN & OPTIMIZATION MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 59 MOLECULAR DESIGN & OPTIMIZATION MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 60 BIOMARKER DISCOVERY MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 61 BIOMARKER DISCOVERY MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 62 STRUCTURE-ACTIVITY RELATIONSHIP (SAR) MODELING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 63 STRUCTURE-ACTIVITY RELATIONSHIP (SAR) MODELING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 64 CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 65 CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 66 CLINICAL DEVELOPMENT MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 67 CLINICAL DEVELOPMENT MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 68 TRIAL DESIGN MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 69 TRIAL DESIGN MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 70 SITE SELECTION MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 71 SITE SELECTION MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 72 RECRUITMENT MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 73 RECRUITMENT MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 74 CLINICAL DATA ASSESSMENT MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 75 CLINICAL DATA ASSESSMENT MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 76 PREDICTIVE TOXICITY & RISK MONITORING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 77 PREDICTIVE TOXICITY & RISK MONITORING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 78 MONITORING & DRUG ADHERENCE MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 79 MONITORING & DRUG ADHERENCE MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 80 REAL-WORLD EVIDENCE (RWE) ANALYSIS MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 81 REAL-WORLD EVIDENCE (RWE) ANALYSIS MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 82 AI IN BIOTECHNOLOGY MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2023-2029 (USD MILLION)
TABLE 83 AI IN BIOTECHNOLOGY MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2030-2035 (USD MILLION)
TABLE 84 AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 85 AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 86 AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY REGION, 2023-2029 (USD MILLION)
TABLE 87 AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY REGION, 2030-2035 (USD MILLION)
TABLE 88 SUPPLY CHAIN PLANNING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 89 SUPPLY CHAIN PLANNING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 90 INVENTORY MANAGEMENT MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 91 INVENTORY MANAGEMENT MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 92 LOGISTICS OPTIMIZATION MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 93 LOGISTICS OPTIMIZATION MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 94 DEMAND FORECASTING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 95 DEMAND FORECASTING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 96 PREDICTIVE MAINTENANCE MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 97 PREDICTIVE MAINTENANCE MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 98 OTHER MANUFACTURING & SUPPLY CHAIN FUNCTIONS MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 99 OTHER MANUFACTURING & SUPPLY CHAIN FUNCTIONS MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 100 AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 101 AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 102 AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY REGION, 2023-2029 (USD MILLION)
TABLE 103 AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY REGION, 2030-2035 (USD MILLION)
TABLE 104 LAUNCH COORDINATION MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 105 LAUNCH COORDINATION MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 106 PATIENT ENGAGEMENT MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 107 PATIENT ENGAGEMENT MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 108 MARKETING OPERATIONS MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 109 MARKETING OPERATIONS MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 110 PREDICTIVE PRICING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 111 PREDICTIVE PRICING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 112 AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 113 AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 114 AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY REGION, 2023-2029 (USD MILLION)
TABLE 115 AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY REGION, 2030-2035 (USD MILLION)
TABLE 116 MEDICATION ADHERENCE MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 117 MEDICATION ADHERENCE MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 118 ADVERSE EVENT REPORTING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 119 ADVERSE EVENT REPORTING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 120 PATIENT MONITORING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 121 PATIENT MONITORING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 122 COMPLIANCE MONITORING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 123 COMPLIANCE MONITORING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 124 PATIENT SUPPORT PROGRAMS MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 125 PATIENT SUPPORT PROGRAMS MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 126 AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 127 AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 128 AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY REGION, 2023-2029 (USD MILLION)
TABLE 129 AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY REGION, 2030-2035 (USD MILLION)
TABLE 130 RISK MANAGEMENT MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 131 RISK MANAGEMENT MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 132 COMPLIANCE MONITORING MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 133 COMPLIANCE MONITORING MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 134 SALES FORCE OPTIMIZATION MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 135 SALES FORCE OPTIMIZATION MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 136 OTHER CORPORATE FUNCTIONS MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 137 OTHER CORPORATE FUNCTIONS MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 138 AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 139 AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 140 AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 141 AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 142 AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY REGION, 2023-2029 (USD MILLION)
TABLE 143 AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY REGION, 2030-2035 (USD MILLION)
TABLE 144 PUBLIC CLOUD MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 145 PUBLIC CLOUD MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 146 PRIVATE CLOUD MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 147 PRIVATE CLOUD MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 148 MULTI CLOUD MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 149 MULTI CLOUD MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 150 HYBRID CLOUD MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 151 HYBRID CLOUD MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 152 AI IN BIOTECHNOLOGY MARKET FOR ON-PREMISES SOLUTIONS, BY REGION, 2023-2029 (USD MILLION)
TABLE 153 AI IN BIOTECHNOLOGY MARKET FOR ON-PREMISES SOLUTIONS, BY REGION, 2030-2035 (USD MILLION)
TABLE 154 AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 155 AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 156 AI IN BIOTECHNOLOGY MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2023-2029 (USD MILLION)
TABLE 157 AI IN BIOTECHNOLOGY MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2030-2035 (USD MILLION)
TABLE 158 AI IN BIOTECHNOLOGY MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2029 (USD MILLION)
TABLE 159 AI IN BIOTECHNOLOGY MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2030-2035 (USD MILLION)
TABLE 160 AI IN BIOTECHNOLOGY MARKET FOR RESEARCH INSTITUTES & LABS, BY REGION, 2023-2029 (USD MILLION)
TABLE 161 AI IN BIOTECHNOLOGY MARKET FOR RESEARCH INSTITUTES & LABS, BY REGION, 2030-2035 (USD MILLION)
TABLE 162 AI IN BIOTECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023-2029 (USD MILLION)
TABLE 163 AI IN BIOTECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2030-2035 (USD MILLION)
TABLE 164 AI IN BIOTECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2029 (USD MILLION)
TABLE 165 AI IN BIOTECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2030-2035 (USD MILLION)
TABLE 166 AI IN BIOTECHNOLOGY MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 167 AI IN BIOTECHNOLOGY MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 168 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
TABLE 169 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY COUNTRY, 2030-2035 (USD MILLION)
TABLE 170 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 171 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 172 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 173 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 174 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 175 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 176 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 177 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 178 NORTH AMERICA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 179 NORTH AMERICA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 180 NORTH AMERICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 181 NORTH AMERICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 182 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 183 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 184 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 185 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 186 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 187 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 188 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 189 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 190 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 191 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 192 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 193 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 194 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 195 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 196 US: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 197 US: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 198 US: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 199 US: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 200 US: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 201 US: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 202 US: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 203 US: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 204 US: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 205 US: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 206 US: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 207 US: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 208 US: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 209 US: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 210 US: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 211 US: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 212 US: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 213 US: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 214 US: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 215 US: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 216 US: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 217 US: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 218 US: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 219 US: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 220 US: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 221 US: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 222 CANADA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 223 CANADA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 224 CANADA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 225 CANADA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 226 CANADA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 227 CANADA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 228 CANADA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 229 CANADA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 230 CANADA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 231 CANADA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 232 CANADA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 233 CANADA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 234 CANADA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 235 CANADA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 236 CANADA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 237 CANADA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 238 CANADA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 239 CANADA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 240 CANADA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 241 CANADA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 242 CANADA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 243 CANADA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 244 CANADA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 245 CANADA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 246 CANADA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 247 CANADA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 248 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
TABLE 249 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY COUNTRY, 2030-2035 (USD MILLION)
TABLE 250 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 251 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 252 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 253 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 254 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 255 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 256 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 257 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 258 EUROPE: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 259 EUROPE: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 260 EUROPE: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 261 EUROPE: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 262 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 263 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 264 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 265 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 266 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 267 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 268 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 269 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 270 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 271 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 272 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 273 EUROPE: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 274 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 275 EUROPE: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 276 GERMANY: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 277 GERMANY: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 278 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 279 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 280 GERMANY: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 281 GERMANY: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 282 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 283 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 284 GERMANY: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 285 GERMANY: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 286 GERMANY: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 287 GERMANY: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 288 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 289 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 290 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 291 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 292 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 293 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 294 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 295 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 296 GERMANY: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 297 GERMANY: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 298 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 299 GERMANY: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 300 GERMANY: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 301 GERMANY: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 302 UK: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 303 UK: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 304 UK: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 305 UK: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 306 UK: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 307 UK: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 308 UK: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 309 UK: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 310 UK: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 311 UK: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 312 UK: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 313 UK: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 314 UK: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 315 UK: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 316 UK: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 317 UK: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 318 UK: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 319 UK: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 320 UK: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 321 UK: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 322 UK: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 323 UK: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 324 UK: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 325 UK: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 326 UK: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 327 UK: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 328 FRANCE: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 329 FRANCE: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 330 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 331 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 332 FRANCE: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 333 FRANCE: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 334 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 335 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 336 FRANCE: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 337 FRANCE: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 338 FRANCE: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 339 FRANCE: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 340 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 341 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 342 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 343 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 344 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 345 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 346 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 347 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 348 FRANCE: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 349 FRANCE: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 350 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 351 FRANCE: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 352 FRANCE: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 353 FRANCE: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 354 ITALY: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 355 ITALY: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 356 ITALY: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 357 ITALY: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 358 ITALY: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 359 ITALY: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 360 ITALY: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 361 ITALY: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 362 ITALY: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 363 ITALY: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 364 ITALY: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 365 ITALY: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 366 ITALY: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 367 ITALY: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 368 ITALY: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 369 ITALY: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 370 ITALY: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 371 ITALY: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 372 ITALY: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 373 ITALY: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 374 ITALY: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 375 ITALY: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 376 ITALY: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 377 ITALY: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 378 ITALY: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 379 ITALY: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 380 SPAIN: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 381 SPAIN: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 382 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 383 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 384 SPAIN: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 385 SPAIN: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 386 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 387 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 388 SPAIN: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 389 SPAIN: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 390 SPAIN: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 391 SPAIN: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 392 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 393 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 394 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 395 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 396 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 397 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 398 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 399 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 400 SPAIN: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 401 SPAIN: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 402 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 403 SPAIN: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 404 SPAIN: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 405 SPAIN: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 406 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 407 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 408 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 409 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 410 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 411 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 412 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 413 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 414 REST OF EUROPE: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 415 REST OF EUROPE: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 416 REST OF EUROPE: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 417 REST OF EUROPE: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 418 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 419 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 420 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 421 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 422 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 423 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 424 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 425 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 426 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 427 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 428 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 429 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 430 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 431 REST OF EUROPE: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 432 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
TABLE 433 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY COUNTRY, 2030-2035 (USD MILLION)
TABLE 434 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 435 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 436 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 437 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 438 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 439 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 440 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 441 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 442 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 443 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 444 ASIA PACIFIC: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 445 ASIA PACIFIC: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 446 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 447 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 448 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 449 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 450 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 451 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 452 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 453 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 454 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 455 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 456 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 457 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 458 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 459 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 460 JAPAN: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 461 JAPAN: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 462 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 463 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 464 JAPAN: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 465 JAPAN: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 466 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 467 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 468 JAPAN: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 469 JAPAN: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 470 JAPAN: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 471 JAPAN: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 472 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 473 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 474 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 475 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 476 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 477 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 478 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 479 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 480 JAPAN: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 481 JAPAN: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 482 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 483 JAPAN: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 484 JAPAN: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 485 JAPAN: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 486 CHINA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 487 CHINA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 488 CHINA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 489 CHINA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 490 CHINA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 491 CHINA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 492 CHINA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 493 CHINA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 494 CHINA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 495 CHINA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 496 CHINA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 497 CHINA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 498 CHINA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 499 CHINA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 500 CHINA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 501 CHINA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 502 CHINA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 503 CHINA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 504 CHINA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 505 CHINA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 506 CHINA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 507 CHINA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 508 CHINA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 509 CHINA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 510 CHINA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 511 CHINA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 512 INDIA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 513 INDIA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 514 INDIA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 515 INDIA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 516 INDIA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 517 INDIA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 518 INDIA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 519 INDIA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 520 INDIA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 521 INDIA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 522 INDIA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 523 INDIA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 524 INDIA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 525 INDIA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 526 INDIA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 527 INDIA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 528 INDIA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 529 INDIA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 530 INDIA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 531 INDIA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 532 INDIA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 533 INDIA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 534 INDIA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 535 INDIA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 536 INDIA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 537 INDIA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 538 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 539 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 540 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 541 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 542 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 543 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 544 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 545 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 546 SOUTH KOREA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 547 SOUTH KOREA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 548 SOUTH KOREA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 549 SOUTH KOREA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 550 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 551 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 552 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 553 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 554 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 555 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 556 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 557 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 558 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 559 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 560 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 561 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 562 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 563 SOUTH KOREA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 564 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 565 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 566 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 567 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 568 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 569 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 570 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 571 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 572 AUSTRALIA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 573 AUSTRALIA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 574 AUSTRALIA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 575 AUSTRALIA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 576 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 577 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 578 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 579 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 580 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 581 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 582 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 583 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 584 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 585 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 586 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 587 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 588 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 589 AUSTRALIA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 590 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 591 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 592 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 593 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 594 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 595 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 596 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 597 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 598 REST OF ASIA PACIFIC: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 599 REST OF ASIA PACIFIC: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 600 REST OF ASIA PACIFIC: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 601 REST OF ASIA PACIFIC: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 602 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 603 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 604 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 605 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 606 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 607 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 608 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 609 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 610 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 611 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 612 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 613 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 614 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 615 REST OF ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 616 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
TABLE 617 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY COUNTRY, 2030-2035 (USD MILLION)
TABLE 618 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 619 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 620 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 621 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 622 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 623 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 624 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 625 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 626 LATIN AMERICA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 627 LATIN AMERICA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 628 LATIN AMERICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 629 LATIN AMERICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 630 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 631 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 632 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 633 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 634 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 635 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 636 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 637 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 638 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 639 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 640 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 641 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 642 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 643 LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 644 BRAZIL: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 645 BRAZIL: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 646 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 647 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 648 BRAZIL: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 649 BRAZIL: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 650 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 651 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 652 BRAZIL: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 653 BRAZIL: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 654 BRAZIL: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 655 BRAZIL: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 656 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 657 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 658 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 659 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 660 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 661 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 662 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 663 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 664 BRAZIL: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 665 BRAZIL: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 666 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 667 BRAZIL: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 668 BRAZIL: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 669 BRAZIL: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 670 MEXICO: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 671 MEXICO: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 672 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 673 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 674 MEXICO: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 675 MEXICO: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 676 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 677 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 678 MEXICO: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 679 MEXICO: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 680 MEXICO: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 681 MEXICO: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 682 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 683 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 684 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 685 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 686 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 687 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 688 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 689 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 690 MEXICO: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 691 MEXICO: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 692 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 693 MEXICO: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 694 MEXICO: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 695 MEXICO: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 696 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 697 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 698 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 699 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 700 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 701 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 702 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 703 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 704 REST OF LATIN AMERICA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 705 REST OF LATIN AMERICA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 706 REST OF LATIN AMERICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 707 REST OF LATIN AMERICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 708 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 709 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 710 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 711 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 712 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 713 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 714 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 715 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 716 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 717 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 718 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 719 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 720 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 721 REST OF LATIN AMERICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 722 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY REGION, 2023-2029 (USD MILLION)
TABLE 723 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY REGION, 2030-2035 (USD MILLION)
TABLE 724 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 725 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 726 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 727 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 728 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 729 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 730 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 731 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 732 MIDDLE EAST & AFRICA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 733 MIDDLE EAST & AFRICA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 734 MIDDLE EAST & AFRICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 735 MIDDLE EAST & AFRICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 736 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 737 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 738 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 739 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 740 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 741 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 742 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 743 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 744 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 745 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 746 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 747 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 748 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 749 MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 750 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 751 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 752 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 753 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 754 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 755 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 756 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 757 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 758 GCC COUNTRIES: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 759 GCC COUNTRIES: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 760 GCC COUNTRIES: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 761 GCC COUNTRIES: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 762 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 763 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 764 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 765 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 766 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 767 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 768 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 769 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 770 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 771 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 772 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 773 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 774 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 775 GCC COUNTRIES: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 776 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2023-2029 (USD MILLION)
TABLE 777 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2030-2035 (USD MILLION)
TABLE 778 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023-2029 (USD MILLION)
TABLE 779 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2030-2035 (USD MILLION)
TABLE 780 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2023-2029 (USD MILLION)
TABLE 781 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2030-2035 (USD MILLION)
TABLE 782 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 783 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 784 REST OF MIDDLE EAST & AFRICA: DRUG DISCOVERY MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 785 REST OF MIDDLE EAST & AFRICA: DRUG DISCOVERY MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 786 REST OF MIDDLE EAST & AFRICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2023-2029 (USD MILLION)
TABLE 787 REST OF MIDDLE EAST & AFRICA: CLINICAL DEVELOPMENT MARKET, BY TYPE, 2030-2035 (USD MILLION)
TABLE 788 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2023-2029 (USD MILLION)
TABLE 789 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR MANUFACTURING & SUPPLY CHAIN, BY TYPE, 2030-2035 (USD MILLION)
TABLE 790 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2023-2029 (USD MILLION)
TABLE 791 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR LAUNCH & COMMERCIAL, BY TYPE, 2030-2035 (USD MILLION)
TABLE 792 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2023-2029 (USD MILLION)
TABLE 793 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR POST-MARKETING SURVEILLANCE & PATIENT SUPPORT, BY TYPE, 2030-2035 (USD MILLION)
TABLE 794 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2023-2029 (USD MILLION)
TABLE 795 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR CORPORATE, BY TYPE, 2030-2035 (USD MILLION)
TABLE 796 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2023-2029 (USD MILLION)
TABLE 797 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2030-2035 (USD MILLION)
TABLE 798 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2023-2029 (USD MILLION)
TABLE 799 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET FOR CLOUD-BASED SOLUTIONS, BY TYPE, 2030-2035 (USD MILLION)
TABLE 800 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2023-2029 (USD MILLION)
TABLE 801 REST OF MIDDLE EAST & AFRICA: AI IN BIOTECHNOLOGY MARKET, BY END USER, 2030-2035 (USD MILLION)
TABLE 802 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN BIOTECHNOLOGY MARKET, JANUARY 2022-NOVEMBER 2025
TABLE 803 AI IN BIOTECHNOLOGY MARKET: DEGREE OF COMPETITION
TABLE 804 AI IN BIOTECHNOLOGY: REGION FOOTPRINT
TABLE 805 AI IN BIOTECHNOLOGY MARKET: COMPONENT FOOTPRINT
TABLE 806 AI IN BIOTECHNOLOGY MARKET: FUNCTION FOOTPRINT
TABLE 807 AI IN BIOTECHNOLOGY MARKET: END-USER FOOTPRINT
TABLE 808 AI IN BIOTECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 809 AI IN BIOTECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY OFFERING, FUNCTION, END USER, AND REGION
TABLE 810 AI IN BIOTECHNOLOGY MARKET: PRODUCT LAUNCHES & UPGRADES, JANUARY 2022-NOVEMBER 2025
TABLE 811 AI IN BIOTECHNOLOGY MARKET: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 812 AI IN BIOTECHNOLOGY MARKET: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
TABLE 813 NVIDIA CORPORATION: COMPANY OVERVIEW
TABLE 814 NVIDIA CORPORATION: PRODUCTS OFFERED
TABLE 815 NVIDIA CORPORATION: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 816 NVIDIA CORPORATION: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 817 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 818 ILLUMINA, INC.: PRODUCTS OFFERED
TABLE 819 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 820 ILLUMINA, INC.: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 821 RECURSION: COMPANY OVERVIEW
TABLE 822 RECURSION: PRODUCTS OFFERED
TABLE 823 RECURSION: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 824 RECURSION: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 825 RECURSION: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
TABLE 826 RECURSION: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 827 SCHRODINGER, INC.: COMPANY OVERVIEW
TABLE 828 SCHRODINGER, INC.: PRODUCTS OFFERED
TABLE 829 SCHRODINGER, INC.: PRODUCT UPGRADES, JANUARY 2022-NOVEMBER 2025
TABLE 830 SCHRODINGER, INC.: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 831 SCHRODINGER, INC.: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 832 BENEVOLENTAI: COMPANY OVERVIEW
TABLE 833 BENEVOLENTAI: PRODUCTS OFFERED
TABLE 834 BENEVOLENTAI: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 835 BENEVOLENTAI: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 836 DATA4CURE, INC.: COMPANY OVERVIEW
TABLE 837 DATA4CURE, INC.: PRODUCTS OFFERED
TABLE 838 DATA4CURE, INC.: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 839 QIAGEN: COMPANY OVERVIEW
TABLE 840 QIAGEN: PRODUCTS OFFERED
TABLE 841 QIAGEN: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 842 QIAGEN: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 843 INSILICO MEDICINE: COMPANY OVERVIEW
TABLE 844 INSILICO MEDICINE: PRODUCTS OFFERED
TABLE 845 INSILICO MEDICINE: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 846 INSILICO MEDICINE: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 847 INSILICO MEDICINE: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 848 DNANEXUS, INC.: COMPANY OVERVIEW
TABLE 849 DNANEXUS, INC.: PRODUCTS OFFERED
TABLE 850 DNANEXUS, INC.: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 851 DNANEXUS, INC.: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 852 TEMPUS: COMPANY OVERVIEW
TABLE 853 TEMPUS: PRODUCTS OFFERED
TABLE 854 TEMPUS: PRODUCT APPROVALS, JANUARY 2022-NOVEMBER 2025
TABLE 855 TEMPUS: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 856 TEMPUS: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 857 SOPHIA GENETICS: COMPANY OVERVIEW
TABLE 858 SOPHIA GENETICS: PRODUCTS OFFERED
TABLE 859 SOPHIA GENETICS: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 860 SOPHIA GENETICS: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 861 SOPHIA GENETICS: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 862 PREDICTIVE ONCOLOGY: COMPANY OVERVIEW
TABLE 863 PREDICTIVE ONCOLOGY: PRODUCTS OFFERED
TABLE 864 PREDICTIVE ONCOLOGY: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 865 PREDICTIVE ONCOLOGY: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 866 PREDICTIVE ONCOLOGY: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
TABLE 867 DEEP GENOMICS: COMPANY OVERVIEW
TABLE 868 DEEP GENOMICS: PRODUCTS OFFERED
TABLE 869 DEEP GENOMICS: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 870 NUMEDII, INC.: COMPANY OVERVIEW
TABLE 871 NUMEDII, INC.: PRODUCTS OFFERED
TABLE 872 XTALPI INC.: COMPANY OVERVIEW
TABLE 873 XTALPI INC.: PRODUCTS OFFERED
TABLE 874 XTALPI INC.: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 875 IKTOS: COMPANY OVERVIEW
TABLE 876 IKTOS: PRODUCTS OFFERED
TABLE 877 IKTOS: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 878 IKTOS: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 879 IKTOS: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 880 BPGBIO, INC.: COMPANY OVERVIEW
TABLE 881 BPGBIO, INC.: PRODUCTS OFFERED
TABLE 882 BPGBIO, INC.: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 883 BPGBIO, INC.: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 884 BPGBIO, INC.: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
TABLE 885 EUROFINS DISCOVERY: COMPANY OVERVIEW
TABLE 886 EUROFINS DISCOVERY: PRODUCTS OFFERED
TABLE 887 EUROFINS DISCOVERY: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
TABLE 888 EUROFINS DISCOVERY: DEALS, JANUARY 2022-NOVEMBER 2025
TABLE 889 EUROFINS DISCOVERY: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
TABLE 890 VERISIM LIFE: COMPANY OVERVIEW
TABLE 891 LIFEBIT BIOTECH INC.: COMPANY OVERVIEW
TABLE 892 VALO HEALTH: COMPANY OVERVIEW
TABLE 893 VERGE GENOMICS: COMPANY OVERVIEW
TABLE 894 LOGICA: COMPANY OVERVIEW
TABLE 895 AMERICAN CHEMICAL SOCIETY: COMPANY OVERVIEW
TABLE 896 AGANITHA AI INC.: COMPANY OVERVIEW

List of Figures

FIGURE 1 AI IN BIOTECHNOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 AI IN BIOTECHNOLOGY MARKET: YEARS CONSIDERED
FIGURE 3 RESEARCH DESIGN
FIGURE 4 PRIMARY SOURCES
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY COMPANY, DESIGNATION, AND REGION
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
FIGURE 8 AI IN BIOTECHNOLOGY MARKET: CAGR PROJECTIONS
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10 DATA TRIANGULATION
FIGURE 11 AI IN BIOTECHNOLOGY MARKET, BY OFFERING, 2025 VS. 2035 (USD MILLION)
FIGURE 12 AI IN BIOTECHNOLOGY MARKET, BY FUNCTION, 2025 VS. 2035 (USD MILLION)
FIGURE 13 AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE, 2025 VS. 2035 (USD MILLION)
FIGURE 14 AI IN BIOTECHNOLOGY MARKET, BY END USER, 2025 VS. 2035 (USD MILLION)
FIGURE 15 AI IN BIOTECHNOLOGY MARKET: REGIONAL SNAPSHOT
FIGURE 16 FOCUS ON COST-EFFECTIVE PROCESSES AND FAVORABLE GOVERNMENT FUNDING TO DRIVE MARKET
FIGURE 17 NORTH AMERICA TO DOMINATE AI IN BIOTECHNOLOGY MARKET DURING STUDY PERIOD
FIGURE 18 END-TO-END SOLUTIONS AND US COMMANDED LARGEST NORTH AMERICAN MARKET SHARE IN 2024
FIGURE 19 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES FROM 2025 TO 2035
FIGURE 21 AI IN BIOTECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 EVOLUTION OF AI IN BIOTECHNOLOGY MARKET
FIGURE 23 AI IN BIOTECHNOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 24 AI IN BIOTECHNOLOGY MARKET: VALUE CHAIN ANALYSIS
FIGURE 25 AI IN BIOTECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
FIGURE 26 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 27 AI IN BIOTECHNOLOGY MARKET: INVESTMENT AND FUNDING SCENARIO
FIGURE 28 AI IN BIOTECHNOLOGY MARKET: PATENT PUBLICATION TRENDS, 2015-2025
FIGURE 29 JURISDICTION AND TOP APPLICANT ANALYSIS, 2015-2025
FIGURE 30 AI IN BIOTECHNOLOGY MARKET: PATENT ANALYSIS, JANUARY 2015-JANUARY 2025
FIGURE 31 MARKET POTENTIAL OF AI/GENERATIVE AI ON AI IN BIOTECHNOLOGY SOLUTIONS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 34 NUMBER OF AI-DISCOVERED MOLECULES IN CLINICAL TRIALS, 2019-2023
FIGURE 35 NORTH AMERICA: AI IN BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE 36 ASIA PACIFIC: AI IN BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN BIOTECHNOLOGY MARKET, 2020-2024 (USD BILLION)
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN BIOTECHNOLOGY MARKET (2024)
FIGURE 39 RANKING OF KEY PLAYERS IN AI IN BIOTECHNOLOGY MARKET (2024)
FIGURE 40 AI IN BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 41 AI IN BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 42 AI IN BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024
FIGURE 43 EV/EBITDA OF KEY VENDORS
FIGURE 44 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF AI IN BIOTECHNOLOGY SOLUTION VENDORS
FIGURE 45 AI IN BIOTECHNOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 46 NVIDIA CORPORATION: COMPANY SNAPSHOT
FIGURE 47 ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 48 RECURSION: COMPANY SNAPSHOT
FIGURE 49 SCHRODINGER, INC.: COMPANY SNAPSHOT
FIGURE 50 BENEVOLENTAI: COMPANY SNAPSHOT
FIGURE 51 QIAGEN: COMPANY SNAPSHOT
FIGURE 52 SOPHIA GENETICS: COMPANY SNAPSHOT
FIGURE 53 PREDICTIVE ONCOLOGY: COMPANY SNAPSHOT
FIGURE 54 XTALPI INC.: COMPANY SNAPSHOT
FIGURE 55 EUROFINS DISCOVERY: COMPANY SNAPSHOT

AI in Biotechnology Market by Function and End User - Global Forecast to 2035

Description

Table of Contents

List of Tables

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the AI in biotechnology marketplace. The breakdown of primary participants is as mentioned below:

This report provides insights into the following:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 INDUSTRY TRENDS

7 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

8 REGULATORY LANDSCAPE

9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

10 AI IN BIOTECHNOLOGY MARKET, BY OFFERING

11 AI IN BIOTECHNOLOGY MARKET, BY FUNCTION

12 AI IN BIOTECHNOLOGY MARKET, BY DEPLOYMENT MODE

13 AI IN BIOTECHNOLOGY MARKET, BY END USER

14 AI IN BIOTECHNOLOGY MARKET, BY REGION

15 COMPETITIVE LANDSCAPE

16 COMPANY PROFILES

17 APPENDIX

List of Tables

List of Figures